| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |